Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

pazopanib_NCRCC,Ph2 STUDY

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2014 by Samsung Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Ho Yeong Lim, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01538238
First received: February 20, 2012
Last updated: March 5, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)